PDF herunterladen
Semin Liver Dis 2019; 39(04): 403-413
DOI: 10.1055/s-0039-1688750
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Critical Review of MELD as a Reliable Tool for Transplant Prioritization

Sophie-Caroline Sacleux
1   Liver Intensive Care Unit, Centre Hépatobiliaire, Paul Brousse Hospital, University of South Paris, Villejuif, Paris, France
,
Didier Samuel
2   Centre Hépatobiliaire, Paul Brousse Hospital, Inserm-Paris Sud research Unit 1193, University Paris Sud, Villejuif, Paris, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
26. Juni 2019 (online)

    Lizenzen und Reprints

Abstract

In a context of global organ shortage, the Model for End-Stage Liver Disease (MELD) score seems to be a fair prioritization tool, with a paradigm: “sickest first.” Since its introduction in the United States in 2002, it has been rapidly adopted by transplant centers and organ sharing agencies around the world. The MELD score showed its effectiveness with a 12% reduction in waiting list mortality in the United States. Its success is linked to its simplicity, the use of basic variables (serum creatinine, serum bilirubin, and international normalized ratio [INR]), and its ability to predict short-term mortality, particularly on the transplant waiting list. However, this score is not perfect: its variables may have disadvantages for some patients, especially women, with serum creatinine and interlaboratory variability of the INR. The MELD score does not take into account some variables associated with poor short-term prognosis in cirrhotic patients. In addition, it is currently capped at 40, which results in the exclusion of sicker patients who could greatly benefit from transplantation. Finally, the MELD score does not accurately reflect the prognosis of several conditions, requiring a MELD exception system. Some solutions have been suggested such as MELD-Na or MELD uncapping, but it has not yet been fully accepted by all transplant centers.

Keywords

Model for End-Stage Liver Disease - liver transplantation - MELD exception - acute-on-chronic liver failure - prioritization
 

  • References

  • 1 Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005; 5 (02) 307-313
    CrossrefPubMedGoogle Scholar
  • 2 Wiesner R, Edwards E, Freeman R. , et al; United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124 (01) 91-96
    CrossrefPubMedGoogle Scholar
  • 3 Freeman Jr RB, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl 2000; 6 (05) 543-552
    CrossrefPubMedGoogle Scholar
  • 4 Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964; 1: 1-85
    PubMedGoogle Scholar
  • 5 Christensen E, Schlichting P, Fauerholdt L. , et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984; 4 (03) 430-435
    CrossrefPubMedGoogle Scholar
  • 6 Kamath PS, Wiesner RH, Malinchoc M. , et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33 (02) 464-470
    CrossrefPubMedGoogle Scholar
  • 7 Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31 (04) 864-871
    CrossrefPubMedGoogle Scholar
  • 8 Wiesner RH, McDiarmid SV, Kamath PS. , et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7 (07) 567-580
    CrossrefPubMedGoogle Scholar
  • 9 Asrani SK, Kamath PS. Model for end-stage liver disease score and MELD exceptions: 15 years later. Hepatol Int 2015; 9 (03) 346-354
    CrossrefPubMedGoogle Scholar
  • 10 Luo X, Leanza J, Massie AB. , et al. MELD as a metric for survival benefit of liver transplantation. Am J Transplant 2018; 18 (05) 1231-1237
    CrossrefPubMedGoogle Scholar
  • 11 Magnusson M, Sten-Linder M, Bergquist A. , et al. The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index. Thromb Res 2013; 132 (03) 346-351
    CrossrefPubMedGoogle Scholar
  • 12 Porte RJ, Lisman T, Tripodi A, Caldwell SH, Trotter JF. ; Coagulation in Liver Disease Study Group. The International Normalized Ratio (INR) in the MELD score: problems and solutions. Am J Transplant 2010; 10 (06) 1349-1353
    CrossrefPubMedGoogle Scholar
  • 13 Trotter JF, Olson J, Lefkowitz J, Smith AD, Arjal R, Kenison J. Changes in international normalized ratio (INR) and Model for End-Stage Liver Disease (MELD) based on selection of clinical laboratory. Am J Transplant 2007; 7 (06) 1624-1628
    CrossrefPubMedGoogle Scholar
  • 14 Tripodi A, Chantarangkul V, Primignani M. , et al. Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score. J Hepatol 2009; 51 (02) 288-295
    CrossrefPubMedGoogle Scholar
  • 15 Abe S, Yoshihisa A, Takiguchi M. , et al. Liver dysfunction assessed by Model for End-Stage Liver Disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure. PLoS One 2014; 9 (06) e100618
    CrossrefPubMedGoogle Scholar
  • 16 Myers RP, Shaheen AAM, Aspinall AI, Quinn RR, Burak KW. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol 2011; 54 (03) 462-470
    CrossrefPubMedGoogle Scholar
  • 17 Cholongitas E, Thomas M, Senzolo M, Burroughs AK. Gender disparity and MELD in liver transplantation. J Hepatol 2011; 55 (02) 500-501
    CrossrefPubMedGoogle Scholar
  • 18 Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41 (01) 32-39
    CrossrefPubMedGoogle Scholar
  • 19 Sharma P, Schaubel DE, Goodrich NP, Merion RM. Serum sodium and survival benefit of liver transplantation. Liver Transpl 2015; 21 (03) 308-313
    CrossrefPubMedGoogle Scholar
  • 20 Biggins SW, Kim WR, Terrault NA. , et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130 (06) 1652-1660
    CrossrefPubMedGoogle Scholar
  • 21 Godfrey EL, Kueht ML, Rana A, Awad S. MELD-Na (the new MELD) and peri-operative outcomes in emergency surgery. Am J Surg 2018; 216 (03) 407-413
    CrossrefPubMedGoogle Scholar
  • 22 Machicao VI. Model for End-Stage Liver Disease-sodium score: the evolution in the prioritization of liver transplantation. Clin Liver Dis 2017; 21 (02) 275-287
    CrossrefPubMedGoogle Scholar
  • 23 Kim WR, Biggins SW, Kremers WK. , et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359 (10) 1018-1026
    CrossrefPubMedGoogle Scholar
  • 24 Nagai S, Chau LC, Schilke RE. , et al. Effects of allocating livers for transplantation based on Model for End-Stage Liver Disease-sodium scores on patient outcomes. Gastroenterology 2018; 155 (05) 1451-1462.e3
    CrossrefPubMedGoogle Scholar
  • 25 Luca A, Angermayr B, Bertolini G. , et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007; 13 (08) 1174-1180
    CrossrefPubMedGoogle Scholar
  • 26 Jurado-García J, Muñoz García-Borruel M, Rodríguez-Perálvarez ML. , et al. Impact of MELD allocation system on waiting list and early post-liver transplant mortality. PLoS One 2016; 11 (06) e0155822
    CrossrefPubMedGoogle Scholar
  • 27 Krell RW, Kaul DR, Martin AR. , et al. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl 2013; 19 (12) 1396-1402
    CrossrefPubMedGoogle Scholar
  • 28 Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol 2014; 20 (25) 8061-8071
    CrossrefPubMedGoogle Scholar
  • 29 Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J. , et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol 2015; 6: e102
    CrossrefPubMedGoogle Scholar
  • 30 van Vugt JLA, Alferink LJM, Buettner S. , et al. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort. J Hepatol 2018; 68 (04) 707-714
    CrossrefPubMedGoogle Scholar
  • 31 Masuda T, Shirabe K, Ikegami T. , et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl 2014; 20 (04) 401-407
    CrossrefPubMedGoogle Scholar
  • 32 Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008; 300 (20) 2371-2378
    CrossrefPubMedGoogle Scholar
  • 33 Cholongitas E, Marelli L, Kerry A. , et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant 2007; 7 (03) 685-692
    CrossrefPubMedGoogle Scholar
  • 34 Bambha K, Kim WR, Kremers WK. , et al. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 2004; 4 (11) 1798-1804
    CrossrefPubMedGoogle Scholar
  • 35 Györi GP, Silberhumer GR, Rahmel A. , et al; Eurotransplant. Impact of dynamic changes in MELD score on survival after liver transplantation - a Eurotransplant registry analysis. Liver Int 2016; 36 (07) 1011-1017
    CrossrefPubMedGoogle Scholar
  • 36 Markwardt D, Holdt L, Steib C. , et al. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis. Hepatology 2017; 66 (04) 1232-1241
    CrossrefPubMedGoogle Scholar
  • 37 Paternostro R, Reiberger T, Mandorfer M. , et al. Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis. J Gastroenterol Hepatol 2017; 32 (01) 184-190
    CrossrefPubMedGoogle Scholar
  • 38 Prasanna KS, Goel A, Amirtharaj GJ. , et al. Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure. Indian J Gastroenterol 2016; 35 (06) 432-440
    CrossrefPubMedGoogle Scholar
  • 39 Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003; 9 (01) 12-18
    CrossrefPubMedGoogle Scholar
  • 40 Huo T-I, Wu J-C, Lin H-C. , et al. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 2005; 42 (06) 826-832
    CrossrefPubMedGoogle Scholar
  • 41 Neuberger J, Gimson A, Davies M. , et al; Liver Advisory Group; UK Blood and Transplant. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008; 57 (02) 252-257
    CrossrefPubMedGoogle Scholar
  • 42 Kartoun U, Corey KE, Simon TG. , et al. The MELD-Plus: a generalizable prediction risk score in cirrhosis. PLoS One 2017; 12 (10) e0186301
    CrossrefPubMedGoogle Scholar
  • 43 Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009; 9 (02) 318-326
    CrossrefPubMedGoogle Scholar
  • 44 Organ Procurement and Transplantation Network (OPTN) Policies. Available at: https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf#nameddest=Policy_09 . Accessed March 26, 2019
    PubMed
  • 45 Dunn S. Executive Summary of the OPTN/UNOS Board of Directors Meeting, December 3–4, 2018. 2018 :18
    PubMedGoogle Scholar
  • 46 Policies and guidance. ODT Clinical - NHS Blood and Transplant. Available at: /transplantation/tools-policies-and-guidance/policies-and-guidance/. Accessed February 26, 2019
    PubMed
  • 47 Jochmans I, van Rosmalen M, Pirenne J, Samuel U. Adult liver allocation in Eurotransplant. Transplantation 2017; 101 (07) 1542-1550
    CrossrefPubMedGoogle Scholar
  • 48 Sharma P, Schaubel DE, Gong Q, Guidinger M, Merion RM. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates. Hepatology 2012; 55 (01) 192-198
    CrossrefPubMedGoogle Scholar
  • 49 Massie AB, Chow EKH, Wickliffe CE. , et al. Early changes in liver distribution following implementation of Share 35. Am J Transplant 2015; 15 (03) 659-667
    CrossrefPubMedGoogle Scholar
  • 50 Kwong AJ, Goel A, Mannalithara A, Kim WR. Improved posttransplant mortality after share 35 for liver transplantation. Hepatology 2018; 67 (01) 273-281
    CrossrefPubMedGoogle Scholar
  • 51 Freeman Jr RB, Gish RG, Harper A. , et al. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 2006; 12 (12) (Suppl. 03) S128-S136
    CrossrefPubMedGoogle Scholar
  • 52 Nadim MK, DiNorcia J, Ji L. , et al. Inequity in organ allocation for patients awaiting liver transplantation: rationale for uncapping the model for end-stage liver disease. J Hepatol 2017; 67 (03) 517-525
    CrossrefPubMedGoogle Scholar
  • 53 Artru F, Louvet A, Ruiz I. , et al. Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3. J Hepatol 2017; 67 (04) 708-715
    CrossrefPubMedGoogle Scholar
  • 54 Levesque E, Hoti E, Azoulay D. , et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 2012; 56 (01) 95-102
    CrossrefPubMedGoogle Scholar
  • 55 Sundaram V, Jalan R, Wu T. , et al. Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation. Gastroenterology 2018; ;(December): S0016-5085(18)35405-2 . Doi: 10.1053/j.gastro.2018.12.007
    PubMedGoogle Scholar
  • 56 Karvellas CJ, Lescot T, Goldberg P. , et al; Canadian Liver Failure Study Group. Liver transplantation in the critically ill: a multicenter Canadian retrospective cohort study. Crit Care 2013; 17 (01) R28 . Doi: 10.1186/cc12508
    CrossrefPubMedGoogle Scholar
  • 57 Michard B, Artzner T, Lebas B. , et al. Liver transplantation in critically ill patients: preoperative predictive factors of post-transplant mortality to avoid futility. Clin Transplant 2017; 31 (12) e13115 . Doi: 10.1111/ctr.13115
    CrossrefPubMedGoogle Scholar
  • 58 Gustot T, Fernandez J, Garcia E. , et al; CANONIC Study Investigators of the EASL-CLIF Consortium. Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology 2015; 62 (01) 243-252
    CrossrefPubMedGoogle Scholar
  • 59 Moreau R, Jalan R, Gines P. , et al; CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144 (07) 1426-1437 , 1437.e1–1437.e9
    CrossrefPubMedGoogle Scholar
  • 60 Levesque E, Saliba F, Ichaï P, Samuel D. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol 2014; 60 (03) 570-578
    CrossrefPubMedGoogle Scholar
  • 61 Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant 2014; 14 (08) 1870-1879
    CrossrefPubMedGoogle Scholar
  • 62 Lai JC, Covinsky KE, Dodge JL. , et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology 2017; 66 (02) 564-574
    CrossrefPubMedGoogle Scholar
  • 63 Samuel D, Coilly A. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation. BMC Med 2018; 16 (01) 113
    CrossrefPubMedGoogle Scholar
  • 64 Goldberg DS, Olthoff KM. Standardizing MELD exceptions: current challenges and future directions. Curr Transplant Rep 2014; 1 (04) 232-237
    PubMedGoogle Scholar
  • 65 Francoz C, Belghiti J, Castaing D. , et al. Model for End-Stage Liver Disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system. Liver Transpl 2011; 17 (10) 1137-1151
    CrossrefPubMedGoogle Scholar
  • 66 Duvoux C, Roudot-Thoraval F, Decaens T. , et al; Liver Transplantation French Study Group. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology 2012; 143 (04) 986-94.e3 , quiz e14–e15
    CrossrefPubMedGoogle Scholar
  • 67 Yao FY, Ferrell L, Bass NM. , et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33 (06) 1394-1403
    CrossrefPubMedGoogle Scholar
  • 68 Schuetz C, Dong N, Smoot E. , et al. HCC patients suffer less from geographic differences in organ availability. Am J Transplant 2013; 13 (11) 2989-2995
    CrossrefPubMedGoogle Scholar
  • 69 Heimbach JK, Hirose R, Stock PG. , et al. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology 2015; 61 (05) 1643-1650
    CrossrefPubMedGoogle Scholar
  • 70 Ishaque T, Massie AB, Bowring MG. , et al. Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change. Am J Transplant 2019; 19 (02) 564-572
    CrossrefPubMedGoogle Scholar
  • 71 Ravaioli M, Grazi GL, Ballardini G. , et al. Liver transplantation with the MELD system: a prospective study from a single European center. Am J Transplant 2006; 6 (07) 1572-1577
    CrossrefPubMedGoogle Scholar
  • 72 Vitale A, Volk ML, De Feo TM. , et al; Liver Transplantation North Italy Transplant program (NITp) working group. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. J Hepatol 2014; 60 (02) 290-297
    CrossrefPubMedGoogle Scholar
  • 73 De Carlis L, Di Sandro S, Centonze L. , et al. Liver-allocation policies for patients affected by HCC in Europe. Curr Transplant Rep 2016; 3 (04) 313-318
    CrossrefPubMedGoogle Scholar
  • 74 Mazzaferro V. Squaring the circle of selection and allocation in liver transplantation for HCC: an adaptive approach. Hepatology 2016; 63 (05) 1707-1717
    CrossrefPubMedGoogle Scholar
  • 75 Amin MG, Wolf MP, TenBrook Jr JA. , et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 2004; 10 (12) 1468-1475
    CrossrefPubMedGoogle Scholar
  • 76 Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA. , et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790
    CrossrefPubMedGoogle Scholar
  • 77 Lee K-W, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006; 82 (12) 1683-1688
    CrossrefPubMedGoogle Scholar
  • 78 Flores A, Asrani SK. The donor risk index: a decade of experience. Liver Transpl 2017; 23 (09) 1216-1225
    CrossrefPubMedGoogle Scholar
  • 79 Schlegel A, Linecker M, Kron P. , et al. Risk assessment in high- and low-MELD liver transplantation. Am J Transplant 2017; 17 (04) 1050-1063
    CrossrefPubMedGoogle Scholar
  • 80 Schrem H, Focken M, Gunson B. , et al. The new liver allocation score for transplantation is validated and improved transplant survival benefit in Germany but not in the United Kingdom. Liver Transpl 2016; 22 (06) 743-756
    CrossrefPubMedGoogle Scholar